NCT03372655

Brief Summary

Determination of prognostic factors affecting ambulation of duchenne muscular dystrophy

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
82

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 6, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 14, 2017

Completed
18 days until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

December 14, 2017

Status Verified

December 1, 2017

Enrollment Period

1 year

First QC Date

December 6, 2017

Last Update Submit

December 10, 2017

Conditions

Duchenne Muscular Dystrophy

Outcome Measures

Primary Outcomes (1)

  • Ten meter walking test

    Questionnaire

    2018 - 2019

Secondary Outcomes (1)

  • Muscle strenght

    2018- 2019

Eligibility Criteria

Age10 Years - 18 Years
Sexmale(Gender-based eligibility)
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Male patient diagnosed as duchenne muscular dystrophy by typical clinical picture\&shooting serum CPK level \& EMG study or biopsy

You may qualify if:

  • any male pt diagnosed as duchenne muscular dystrophy by typical clinical picture \&shooting serum CPK level \&EMG study or biopsy \& age 10 to 18yrs old

You may not qualify if:

  • female patient ' age below 10 yrs old or above 18 yrs old .patient with autoimmune disease or malignancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Muscular Dystrophy, Duchenne

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, X-LinkedGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Nehal Refaat, Residant

CONTACT

01000242438nehalrefaatmohammed@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sponsor investigator

Study Record Dates

First Submitted

December 6, 2017

First Posted

December 14, 2017

Study Start

January 1, 2018

Primary Completion

January 1, 2019

Study Completion

March 1, 2019

Last Updated

December 14, 2017

Record last verified: 2017-12